In Vitro and In Vivo safety evaluation studies are conducted on a variety of biomaterials, medical devices and related products to identify the presence of toxins or other potentially harmful effects. Biocompatibility testing for medical devices ranges from initial screening of new materials to product release testing and non-clinical or pre-market safety evaluations to ensure your device meets current global standards.
At NAMSA, we understand the confidence you require in your biocompatibility testing partner to deliver high-quality, accurate results on your way to commercialization. Our highly trained experts perform all tests in house to evaluate your device’s component material / finished product use and regulatory pathway — minimizing cost and development time.
NAMSA has over 50 years of experience providing biocompatibility testing services worldwide. That equates to unparalleled support for sponsors in the United States, United Kingdom, Ireland, Spain, France, Germany and many other countries worldwide.